@article{2b6d2fd6ff4747b39b6567673e811451,
title = "Imidazole: A selective inhibitor of thromboxane synthetase",
abstract = "Imidazole inhibits the enzymatic conversion of the endoperoxides (PGG2 and PGH2) to thromboxane A2 by platelet microsomes (IC50: 22 μg/ml; determined by bioassay). The inhibitor is selective, for prostaglandin cyclo-oxygenase is only affected at high doses. Radiochemical data confirms that imidazole blocks the formation of 14C-thromboxane B2 from 14C-PHG2. Several imidazole analogues and other substances were tested but only 1-methyl-imidadole was more potent that imidazole iteself. The use of imidazole of inhibit thromboxane formation could help to elucidate the role of thromboxanes in physiology or pathophysiology.",
author = "Salvador Moncada and Stuart Bunting and Kevin Mullane and Peter Thorogood and Vane, {John R.} and Amiram Raz and Philip Needleman",
note = "Funding Information: Supported in part by NIH Grants: SCOR HL-17646, HE-14397 and an American Heart Grant-in-Aid.",
year = "1977",
month = apr,
doi = "10.1016/0090-6980(77)90232-5",
language = "אנגלית",
volume = "13",
pages = "611--618",
journal = "Prostaglandins",
issn = "0090-6980",
publisher = "Elsevier BV",
number = "4",
}